Document is current
Any future updates will be listed below
-
Authors
Hong, Shaodong
Wang, Qiming
Cheng, Ying https://orcid.org/0000-0001-9908-597X
Luo, Yongzhong
Qu, Xiujuan
Zhu, Haibo
Ding, Zhenyu
Li, Xingya
Wu, Lin https://orcid.org/0000-0001-7078-7767
Wang, Yan
Hu, Sheng
Wang, Enwen
Liu, Anwen
Sun, Yuping
Fan, Yun
Ye, Feng
Lu, Kaihua
Fang, Jian
Shen, Yuping
Jin, Xiaoping
Ge, Junyou
Zhang, Li https://orcid.org/0000-0003-0595-0761
Fang, Wenfeng https://orcid.org/0000-0002-6440-8246
- License Information
-
More Information
Article History
Received: 16 August 2024
Accepted: 3 July 2025
First Online: 19 August 2025
Competing interests
: Y. Shen, X.J. and J.G. are employees of Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. L.Z. has received research support from Hengrui, BeiGene, Xiansheng, Eli Lilly, Novartis, Roche, Hansoh and Bristol-Myers Squibb Pharma, and consulting for MSD, Beigene and Xiansheng Pharma. The other authors declare no competing interests.
